top of page

Nanomedicine In a Box

The formulation of RNA-loaded lipid nanoparticles (LNPs) is essential for the development of new therapies and vaccines. Yet current LNP formulating is often slow, complex, and expensive, a major bottleneck in therapeutic innovation.

​

Developed by Nanofacile, Nanomedicine in a Box is a game-changer. This innovative platform simplifies and accelerates LNP formulation, offering a turnkey solution for laboratories, biotech companies, and the pharmaceutical industry.

Packaging Mockup
Screenshot 2025-06-05 at 9.28_edited.jpg

Why choose Nanomedicine in a Box ?

DSC_0114_edited.jpg

Reliability and
reproducibility

Delivers consistent, high quality results, every time.

Flexibility_edited.jpg

Flexibility

Engineered for versatility across RNA types and delivery systems

gopi qnd alejandro.png

Ease of use

Simple to set up. Easy to learn. Ready to run.

Packaging Mockup

Innovative high-throughput (HT) platform

Up to 28 formulations simultaneously

Integrates with standard laboratory equipment

Reduces preclinical timelines from several weeks to a few days

Cost-effective solution

30-second encapsulation per sample

Be part of the breakthrough !

Nanomedicine in a Box is scheduled for launch in 2026. Interested in getting a first look?

Join our beta program and help shape the future of nanomedicine.

Logo Nanofacile
Symbole localisation

NANOFACILE OFFICE

800 Rue du Square-Victoria, Montreal, Quebec, H3C 0B4

Symbole localisation

NANOFACILE LABORATORY

7141 Sherbrooke Ouest,

Montreal, Quebec, H4B 1R6

Symbole e-mail
Untitled design-2_edited.jpg
Symbole LinkedIn

Copyright © 2024 Nanofacile Inc. All rights reserved.

bottom of page